Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 778
117th Congress(2021-2022)
Protecting Children From Experimentation Act of 2021
Introduced
Introduced
Introduced in Senate on Mar 16, 2021
Overview
Text
Introduced in Senate 
Mar 16, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Mar 16, 2021)
Mar 16, 2021
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 778 (Introduced-in-Senate)


117th CONGRESS
1st Session
S. 778


To amend chapter 110 of title 18, United States Code, to prohibit gender reassignment medical interventions on minors, and for other purposes.

IN THE SENATE OF THE UNITED STATES

March 16, 2021

Mr. Marshall (for himself, Mr. Braun, Mrs. Blackburn, and Mrs. Hyde-Smith) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To amend chapter 110 of title 18, United States Code, to prohibit gender reassignment medical interventions on minors, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Protecting Children From Experimentation Act of 2021”.

SEC. 2. Gender reassignment medical interventions on minors prohibited.

Chapter 110 of title 18, United States Code, is amended—

(1) by adding at the end the following:

Ҥ 2260B. Gender reassignment medical interventions on minors

“(a) In general.—Whoever knowingly performs any gender reassignment medical intervention on a minor shall be fined under this title, imprisoned not more than 5 years, or both.

“(b) Prohibition on prosecution of person on whom intervention is performed.—No person on whom the gender reassignment medical intervention under subsection (a) is performed may be arrested or prosecuted for an offense under this section.

“(c) Civil action.—A person on whom a gender reassignment medical intervention is performed under this section may bring a civil action for appropriate relief against each person who performed the gender reassignment medical intervention.

“(d) Definitions.—In this section:

“(1) GENDER REASSIGNMENT MEDICAL INTERVENTION.—

“(A) IN GENERAL.—For purposes of this chapter, except as provided in subparagraph (B), the term ‘gender reassignment medical intervention’ means—

“(i) performing a surgery that sterilizes an individual, including castration, vasectomy, hysterectomy, oophorectomy, metoidioplasty, penectomy, phalloplasty, and vaginoplasty, to change the body of such individual to correspond to a sex that is discordant with biological sex;

“(ii) performing a mastectomy on an individual for the purpose described in clause (i); or

“(iii) administering or supplying to an individual medications for the purpose described in clause (i), including—

“(I) GnRH agonists or other puberty-blocking drugs to stop or delay normal puberty;

“(II) testosterone or other androgens to biological females at doses that are supraphysiologic to the female sex; or

“(III) estrogen to biological males at doses that are supraphysiologic to the male sex.

“(B) EXCEPTION.—Subparagraph (A) shall not apply to the following individuals:

“(i) An individual with external biological sex characteristics that are irresolvably ambiguous, such as those born with 46 XX chromosomes with virilization, 46 XY chromosomes with undervirilization, or having both ovarian and testicular tissue.

“(ii) An individual with respect to whom a physician has determined through genetic or biochemical testing that the individual does not have normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action for a biological male or biological female.

“(2) MINOR.—The term ‘minor’ means any person under the age of eighteen years.”; and

(2) by amending the table of sections for such chapter by adding at the end the following:


“2260B. Gender reassignment medical interventions on minors.”.